HomeCompareCOBJF vs MRK

COBJF vs MRK: Dividend Comparison 2026

COBJF yields 689.27% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 COBJF wins by $559.8K in total portfolio value
10 years
COBJF
COBJF
● Live price
689.27%
Share price
$0.29
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$617.5K
Annual income
$2,105.83
Full COBJF calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — COBJF vs MRK

📍 COBJF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCOBJFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, COBJF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
COBJF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

COBJF
Annual income on $10K today (after 15% tax)
$58,588.37/yr
After 10yr DRIP, annual income (after tax)
$1,789.96/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, MRK beats the other by $6,806.76/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of COBJF + MRK for your $10,000?

COBJF: 50%MRK: 50%
100% MRK50/50100% COBJF
Portfolio after 10yr
$337.6K
Annual income
$6,109.80/yr
Blended yield
1.81%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

COBJF
No analyst data
Altman Z
2.5
Piotroski
3/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

COBJF buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCOBJFMRK
Forward yield689.27%2.81%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%32.7%
Portfolio after 10y$617.5K$57.7K
Annual income after 10y$2,105.83$10,113.78
Total dividends collected$387.6K$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: COBJF vs MRK ($10,000, DRIP)

YearCOBJF PortfolioCOBJF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$45,164$34,463.74$11,213$373.04+$34.0KCOBJF
2$121,059$72,734.19$12,667$512.06+$108.4KCOBJF
3$220,637$91,103.16$14,439$708.14+$206.2KCOBJF
4$313,670$77,588.78$16,640$988.16+$297.0KCOBJF
5$387,171$51,544.27$19,432$1,394.07+$367.7KCOBJF
6$444,003$29,730.12$23,057$1,992.90+$420.9KCOBJF
7$491,015$15,931.84$27,889$2,894.79+$463.1KCOBJF
8$533,620$8,233.06$34,518$4,286.29+$499.1KCOBJF
9$575,154$4,181.04$43,912$6,494.35+$531.2KCOBJF
10$617,521$2,105.83$57,714$10,113.78+$559.8KCOBJF

COBJF vs MRK: Complete Analysis 2026

COBJFStock

Comba Telecom Systems Holdings Limited, an investment holding company, engages in research, development, manufacture, and sale of wireless telecommunications network system equipment and related engineering services. It operates through two segments, Wireless Telecommunications Network System Equipment and Services, and Operator Telecommunication Services. The company provides base station antennas and subsystems; network system products, including macro and small cells, and open RAN products, as well as related extended and in-depth coverage solutions; and software technology, technical support, value-added, and repairing services. It also engages in the trading and marketing of wireless telecommunications network system equipment; research and development, and trading of digital microwave system equipment; and provision of hardware and software solutions and services. The company serves the airport, education, government and public safety, healthcare, hospitality, retail, stadium, and transportation industries. It operates in Mainland China, rest of Asia Pacific, the Americas, the European Union, the Middle East, and internationally. The company was founded in 1997 and is headquartered in Tai Po, Hong Kong.

Full COBJF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this COBJF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

COBJF vs SCHDCOBJF vs JEPICOBJF vs OCOBJF vs KOCOBJF vs MAINCOBJF vs JNJCOBJF vs ABBVCOBJF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.